Richard D. Boyce

2.4k total citations
99 papers, 1.6k citations indexed

About

Richard D. Boyce is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Richard D. Boyce has authored 99 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 23 papers in Pharmacology and 22 papers in Computational Theory and Mathematics. Recurrent topics in Richard D. Boyce's work include Biomedical Text Mining and Ontologies (43 papers), Computational Drug Discovery Methods (22 papers) and Pharmaceutical Practices and Patient Outcomes (17 papers). Richard D. Boyce is often cited by papers focused on Biomedical Text Mining and Ontologies (43 papers), Computational Drug Discovery Methods (22 papers) and Pharmaceutical Practices and Patient Outcomes (17 papers). Richard D. Boyce collaborates with scholars based in United States, Austria and Netherlands. Richard D. Boyce's co-authors include John R. Horn, Daniel C. Malone, Matthias Samwald, Steven M. Handler, Timothy M. Rose, Patrick Ryan, Sandra L. Kane‐Gill, Philip E. Empey, Joseph T. Hanlon and Carol Collins and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Richard D. Boyce

98 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard D. Boyce United States 23 487 285 279 252 221 99 1.6k
Jon Duke United States 23 465 1.0× 161 0.6× 463 1.7× 112 0.4× 213 1.0× 52 2.2k
John R. Horn United States 26 371 0.8× 431 1.5× 84 0.3× 339 1.3× 145 0.7× 118 2.8k
Preciosa M. Coloma Netherlands 25 216 0.4× 138 0.5× 123 0.4× 124 0.5× 208 0.9× 46 1.9k
Paul Avillach United States 29 351 0.7× 52 0.2× 177 0.6× 86 0.3× 162 0.7× 83 2.1k
Christian Reich United States 21 575 1.2× 88 0.3× 617 2.2× 83 0.3× 138 0.6× 57 3.0k
G. Niklas Norén Sweden 26 405 0.8× 123 0.4× 368 1.3× 159 0.6× 580 2.6× 63 2.9k
Paea LePendu United States 21 571 1.2× 57 0.2× 504 1.8× 76 0.3× 274 1.2× 40 1.9k
Herbert Chase United States 24 830 1.7× 75 0.3× 293 1.1× 73 0.3× 299 1.4× 56 1.8k
Judith A. Racoosin United States 15 174 0.4× 69 0.2× 108 0.4× 107 0.4× 104 0.5× 27 2.1k
Rave Harpaz United States 21 725 1.5× 105 0.4× 322 1.2× 221 0.9× 884 4.0× 34 2.0k

Countries citing papers authored by Richard D. Boyce

Since Specialization
Citations

This map shows the geographic impact of Richard D. Boyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Boyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Boyce more than expected).

Fields of papers citing papers by Richard D. Boyce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Boyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Boyce. The network helps show where Richard D. Boyce may publish in the future.

Co-authorship network of co-authors of Richard D. Boyce

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Boyce. A scholar is included among the top collaborators of Richard D. Boyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Boyce. Richard D. Boyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kane‐Gill, Sandra L., et al.. (2024). Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System. Pharmacology Research & Perspectives. 13(1). e70047–e70047. 1 indexed citations
2.
Kane‐Gill, Sandra L., et al.. (2024). Part 1: Evaluation of Pediatric Cannabis–Drug Interaction Reports. Pharmacology Research & Perspectives. 13(1). e70046–e70046. 1 indexed citations
3.
Gephart, Sheila M., Vignesh Subbian, Richard D. Boyce, et al.. (2023). Barriers to Adoption of Tailored Drug–Drug Interaction Clinical Decision Support. Applied Clinical Informatics. 14(4). 779–788. 2 indexed citations
4.
Callahan, Tiffany J., Mary F. Paine, Sandra L. Kane‐Gill, et al.. (2023). Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions. Journal of Biomedical Informatics. 140. 104341–104341. 8 indexed citations
5.
Albert, Steven M., C. Elizabeth Shaaban, Helmet T. Karim, et al.. (2023). Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: A use case studying depression as a risk factor for Alzheimer’s disease. Journal of Biomedical Informatics. 142. 104368–104368. 7 indexed citations
6.
Li, Qian, Xi Yang, Jie Xu, et al.. (2023). Early prediction of Alzheimer's disease and related dementias using real‐world electronic health records. Alzheimer s & Dementia. 19(8). 3506–3518. 51 indexed citations
7.
Boyce, Richard D., Ainhoa Gómez-Lumbreras, Lorenzo Villa Zapata, et al.. (2022). Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C). BMJ Open. 12(12). e066846–e066846. 6 indexed citations
8.
Kim, Hyunwoo, et al.. (2021). Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database. Respiratory Care. 66(11). 1739–1745. 2 indexed citations
9.
Gufford, Brandon T., et al.. (2020). A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From Chemical Characterization to Clinical Studies. Drug Metabolism and Disposition. 48(10). 1104–1112. 12 indexed citations
10.
Boyce, Richard D., et al.. (2019). A proposal for determining the evidence types of biomedical documents using a drug-drug interaction ontology and machine learning. 2350. 2 indexed citations
11.
Demner‐Fushman, Dina, et al.. (2018). Overview of the TAC 2018 Drug-Drug Interaction Extraction from Drug Labels Track.. Theory and applications of categories. 8 indexed citations
12.
Demner‐Fushman, Dina, et al.. (2018). Adverse Reactions and Drug-Drug Interaction Extraction tracks at the Text Analysis Conference (TAC).. AMIA. 1 indexed citations
13.
Nelson, Scott D., et al.. (2017). Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews. BMC Medical Informatics and Decision Making. 17(1). 21–21. 26 indexed citations
14.
Voss, Erica A., et al.. (2016). Accuracy of an automated knowledge base for identifying drug adverse reactions. Journal of Biomedical Informatics. 66. 72–81. 69 indexed citations
15.
Horn, John R., et al.. (2015). Utilizing the Wikidata System to Improve the Quality of Medical Content in Wikipedia in Diverse Languages: A Pilot Study. Journal of Medical Internet Research. 17(5). e110–e110. 14 indexed citations
16.
Rastegar-Mojarad, Majid, Richard D. Boyce, & Rashmi Prasad. (2013). UWM-TRIADS: Classifying Drug-Drug Interactions with Two-Stage SVM and Post-Processing. Joint Conference on Lexical and Computational Semantics. 667–674. 16 indexed citations
17.
Boyce, Richard D., Steven M. Handler, Jordan F. Karp, & Joseph T. Hanlon. (2012). Age-Related Changes in Antidepressant Pharmacokinetics and Potential Drug-Drug Interactions: A Comparison of Evidence-Based Literature and Package Insert Information. ˜The œAmerican journal of geriatric pharmacotherapy. 10(2). 139–150. 32 indexed citations
18.
Boyce, Richard D., Gregory C. Gardner, & Henk Harkema. (2012). Using Natural Language Processing to Extract Drug-Drug Interaction Information from Package Inserts. North American Chapter of the Association for Computational Linguistics. 206–213. 9 indexed citations
19.
Boyce, Richard D., Joseph T. Hanlon, Jordan F. Karp, et al.. (2011). A Review of the Effectiveness of Antidepressant Medications for Depressed Nursing Home Residents. Journal of the American Medical Directors Association. 13(4). 326–331. 35 indexed citations
20.
Marcum, Zachary A., Steven M. Handler, Richard D. Boyce, Walid F. Gellad, & Joseph T. Hanlon. (2010). Medication misadventures in the elderly: A year in review. ˜The œAmerican journal of geriatric pharmacotherapy. 8(1). 77–83. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jon Duke Breakdown of academic impact, for papers by John R. Horn Breakdown of academic impact, for papers by Preciosa M. Coloma Breakdown of academic impact, for papers by Paul Avillach Breakdown of academic impact, for papers by Christian Reich Breakdown of academic impact, for papers by G. Niklas Norén Breakdown of academic impact, for papers by Paea LePendu Breakdown of academic impact, for papers by Herbert Chase Breakdown of academic impact, for papers by Judith A. Racoosin Breakdown of academic impact, for papers by Rave Harpaz
Rankless by CCL
2026